市場調查報告書

場外(OTC)藥品市場:2019-2025

Over the Counter (OTC) Drugs Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 949646
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
場外(OTC)藥品市場:2019-2025 Over the Counter (OTC) Drugs Market 2019-2025
出版日期: 2020年06月23日內容資訊: 英文
簡介

在預測期內,預計全球非處方藥(OTC)市場將顯著增長。非處方藥直接在雙方之間購買,無需醫生處方或監督。 OTC藥物不需要臨床試驗。促成市場增長的因素是全球OTC藥物的可負擔性。此外,通過在線分銷渠道獲得的非處方藥有望為市場創造未來的增長機會。由於電子商務行業的發展,再加上互聯網的普及,在預測期內,在線分銷渠道預計將以顯著速度增長。

在地理上,預計亞太地區將在預測期內顯示出顯著的市場增長。該地區人口老齡化的增長正在推動市場增長。此外,改善醫療基礎設施將進一步支持區域市場增長。

該報告調查了全球非處方藥(OTC)市場,並提供了該市場的概述,以及按產品類型,分銷渠道,區域,競爭格局以及進入市場的公司的概況的趨勢。

內容

第1章報告概述

第2章市場概述和見解

  • 調查範圍
  • 分析師見解和當前市場趨勢
  • 規則與規定

第3章競爭情況

  • 公司佔有率分析
  • 主要策略分析
  • 主要公司分析
    • Bayer AG
    • GlaxoSmithKline Plc
    • Novartis International AG
    • Pfizer, Inc
    • Sanofi SA

第4章市場決定因素

動機

抑製器

  • 機會

第5章市場細分

  • 按產品類型劃分的市場
    • 止痛藥和止痛藥
    • 咳嗽,感冒,感冒藥
    • 維生素和礦物質補充劑
    • 眼科產品
    • 其他
  • 按分銷渠道劃分的市場
    • 零售和超級市場
    • 在線平台

第6章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章公司簡介

  • Achelios therapeutics., Inc.
  • Alkem Laboratories Ltd.
  • Amgen Inc.
  • Amway Corp.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Novartis International AG
  • Perrigo Co. plc
  • Pfizer, Inc
  • Reckitt Benckiser Group plc
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
目錄
Product Code: OMR2021965

Global Over the Counter (OTC) Drugs Market Size, Share & Trends Analysis Report By Product Type (Analgesics & Pain Relievers; Cough, Cold & Flu Products; Vitamin & Mineral Supplements; Ophthalmic Products; and Others), By Distribution Channel (Retail & Supermarkets and Online Platform), and Forecast 2019-2025

The global Over the Counter (OTC) drugs market is anticipated to grow significantly during the forecast period. Over the Counter drugs are purchased directly between two parties, without the supervision of an exchange or prescription by physician. OTC drugs don't require any clinical trials. The factor contributing to the growth of the market includes the affordable price of OTC drugs across the globe. Further, the availability of OTC drugs on online distribution channel tends to create an opportunity for the future growth of the market.

The global Over the counter (OTC) drugs market is segmented based on product type and distribution channel. Based on the product type, the market is sub-segmented into the analgesics & pain relievers; cough, cold & flu products; vitamin & mineral supplements; ophthalmic products; and others. Vitamin & mineral supplements segment is estimated to exhibit considerable growth rate during the forecast period owing to the increasing awareness among the general population regarding health. Based on the distribution channel, the market is bifurcated into retail & supermarkets and online platform. Online distribution channel is estimated to grow at a significant rate during the forecast period owing to the growing e-commerce industry coupled with increasing internet penetration.

Geographically, the study of the global over the counter (OTC) drugs market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global over the counter (OTC) drugs market during the forecast period. The increasing geriatric population in the region drives the growth of the market. In addition, improving healthcare infrastructure further gives a boost to the regional growth of the market.

Moreover, the study of the global over the counter (OTC) drugs market report covers the analysis of various players operating in the market. Some of the key players covered in the report include Bayer AG, GlaxoSmithKline Plc, Novartis International AG, Merck KGaA, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., and others.

Research Methodology

The market study of the global OTC drugs market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for the government organizations, pharmaceuticals companies, pharmacies and other related industries for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Over the Counter (OTC) drugs Market Research and Analysis by Product Type

The Report Covers:

  • Comprehensive research methodology of the global OTC drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global OTC drugs market.
  • Insights about market determinants which are stimulating the global OTC drugs market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Bayer AG
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. GlaxoSmithKline Plc
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Novartis International AG
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Pfizer, Inc
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Sanofi SA
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
    • 4.1. Opportunities

5. Market Segmentation

  • 5.1. Over the Counter (OTC) drug Market by Product Type
    • 5.1.1. Analgesics and Pain Relievers
    • 5.1.2. Cough, Cold and Flu Products
    • 5.1.3. Vitamin & Mineral Supplements
    • 5.1.4. Ophthalmic Products
    • 5.1.5. Others
  • 5.2. Over the Counter (OTC) drug Market by Distribution Channel
    • 5.2.1. Retail & Supermarket
    • 5.2.2. Online Platform

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Achelios therapeutics., Inc.
  • 7.2. Alkem Laboratories Ltd.
  • 7.3. Amgen Inc.
  • 7.4. Amway Corp.
  • 7.5. AstraZeneca PLC
  • 7.6. Bayer AG
  • 7.7. Boehringer Ingelheim International GmbH
  • 7.8. Bristol-Myers Squibb Co.
  • 7.9. Cipla Ltd.
  • 7.10. Dr. Reddy's Laboratories Ltd.
  • 7.11. GlaxoSmithKline Plc
  • 7.12. Glenmark Pharmaceuticals Ltd
  • 7.13. Johnson & Johnson Services, Inc.
  • 7.14. Merck KGaA
  • 7.15. Novartis International AG
  • 7.16. Perrigo Co. plc
  • 7.17. Pfizer, Inc
  • 7.18. Reckitt Benckiser Group plc
  • 7.19. Sanofi SA
  • 7.20. Sun Pharmaceutical Industries Ltd.
  • 7.21. Teva Pharmaceutical Industries Ltd.

LIST OF TABLES

  • 1. GLOBAL OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL ANALGESICS AND PAIN RELIEVERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL COUGH, COLD AND FLU PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL DERMATOLOGICAL PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL GASTROINTESTINAL PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL OPHTHALMIC PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2018-2025 ($ MILLION)
  • 10. GLOBAL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL VITAMIN AND HEALTH FOOD STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. NORTH AMERICA OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 14. NORTH AMERICAN OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 15. NORTH AMERICAN OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2018-2025 ($ MILLION)
  • 16. EUROPE OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 17. EUROPE OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 18. EUROPE OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2018-2025 ($ MILLION)
  • 19. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 20. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 21. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2018-2025 ($ MILLION)
  • 22. REST OF THE WORLD OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 23. REST OF THE WORLD OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL OVER THE COUNTER (OTC) DRUG MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL OVER THE COUNTER (OTC) DRUG MARKET SHARE BY DISTRIBUTION CHANNEL, 2018 VS 2025 (%)
  • 3. GLOBAL OVER THE COUNTER (OTC) DRUG MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)